FOAMIX
Foamix has a strong in-house pipeline of drugs for dermatologic, ophthalmologic and gynecologic indications. The Company’s lead product under development is the first-in-class Topical Minocycline Foam addressing large markets in dermatology and ophthalmology. Minocycline foam demonstrated high efficacy and favorable safety in two phase II clinical studies in Acne and Impetigo patients. Foamix Ltd. is a clinical-stage, privately held specialty pharmaceutical company, focused on the development of proprietary topical foams and OilGel™ products for dermatology, gynecology, wounds and burns as well as ophthalmic disorders.
FOAMIX
Social Links:
Industry:
Clinical Trials Health Care Pharmaceutical
Founded:
2003-01-01
Address:
Rehovot, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.foamix.com
Total Employee:
11+
Status:
Active
Contact:
(972) 893-1623
Email Addresses:
[email protected]
Total Funding:
197 M USD
Technology used in webpage:
IPhone / Mobile Compatible SPF Font Awesome Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Barracuda Networks
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Debt - Foamix
OrbiMed
OrbiMed investment in Post-IPO Debt - Foamix
OrbiMed
OrbiMed investment in Post-IPO Equity - Foamix
Official Site Inspections
http://www.foamix.com Semrush global rank: 4.98 M Semrush visits lastest month: 1.7 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
